Pharmstandard Strategic SWOT Analysis Review Report Updated 13122018 Prices from USD $125

Pharmstandard Strategic SWOT Analysis Review [Report Updated: 13122018] Prices from USD $125

06:58 EST 26 Jan 2019 | BioPortfolio Reports

Pharmstandard Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.


This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Scope


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Highlights


Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and overthe drug OTC pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services. Pharmstandard's product portfolio includes drugs for treatments of cardiovascular diseases, cancer, gastroenterology diseases, neurology diseases, diabetes, contagious diseases, growth hormone deficiency, metabolic disorders and other diseases. The company serves customers in The Commonwealth of Independent States CIS and Former Soviet Union FSU countries. Pharmstandard is headquartered in Dolgoprudny, Moscow Oblast, Russia.


Pharmstandard Key Recent Developments


May 24,2017: Pharmstandard has changed its legal form

May 18,2017: Pharmstandard wins the AllRussian open competition "Platinum Ounce2016"

May 03,2017: Pharmstandard wins the BEST.RU 2016 award

Mar 24,2017: Pharmstandard, Rostec and Kedrion Biopharma Signed an Agreement to Establish JSC Kirov Plasma


Reasons to Buy


Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.


Note: Some sections may be missing if data is unavailable for the company.

More From BioPortfolio on "Pharmstandard Strategic SWOT Analysis Review [Report Updated: 13122018] Prices from USD $125"